AZN | AstraZenecaNYSECommon stock golden cross and death cross projections, cross tests and history

$183.88
-$2.70 (-1.45%)

AstraZeneca (AZN) is a NYSE-listed common stock that Cruxta has tracked for 50/200 crosses since 2019.

Right now the daily is the chart to watch. The 50 SMA has sat below the 200 since Jul 2026, but the two have been closing on each other and a golden cross is projected within 30 bars. Price sits above the 50 and the 200 on the daily, the weekly and the 4-hour.

Timeframe summary

Weekly as of 30 Oct 16:00 ET

Price
above both $186.65 vs 50 $181.29 / 200 $153.28
Projection
No cross projected
Test
No active test
Last cross
No cross on record

4-hour as of 3 Nov 13:30 ET

Price
above both $184.08 vs 50 $166.36 / 200 $168.54
Projection
Golden cross projected in 6 bars
Test
No active test
Last cross
Death cross 13 May 2026 ยท projected 28 bars out

Cross history

28
crosses on record since 2019
13 golden15 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
9 Jul 2026Death moderatedaily3 bars outNot tested
13 May 2026Death4-hour28 bars outNot tested
1 Aug 2025Golden4-hour24 bars outโ€”
23 Jul 2025Golden flatdaily18 bars outNot tested
23 Apr 2025Death4-hour24 bars outโ€”

About AZN

ExchangeNYSE
InstrumentCommon stock
Median $ volume, 60 d$503M
4-hour coverageYes, since Oct 2025
History on recordSince 2019
Cap bandmega

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.